S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
NASDAQ:PSNL

Personalis - PSNL Stock Forecast, Price & News

$3.90
+0.86 (+28.29%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.93
$4.25
50-Day Range
$1.78
$3.90
52-Week Range
$1.73
$12.96
Volume
7.85 million shs
Average Volume
316,641 shs
Market Capitalization
$179.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

Personalis MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
233.3% Upside
$13.00 Price Target
Short Interest
Bearish
4.68% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.20mentions of Personalis in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$48,910 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.46) to ($2.37) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Medical Sector

211th out of 1,028 stocks

Medical Laboratories Industry

6th out of 25 stocks

PSNL stock logo

About Personalis (NASDAQ:PSNL) Stock

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Receive PSNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Personalis and its competitors with MarketBeat's FREE daily newsletter.

PSNL Stock News Headlines

Why Personalis Shares Are Trading Higher Today
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Personalis Announces CEO Retirement and Transition
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Personalis Reports Third Quarter 2022 Financial Results
Personalis, Inc. (NASDAQ: PSNL)
Is Personalis (NASDAQ:PSNL) Using Debt Sensibly?
See More Headlines
Receive PSNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Personalis and its competitors with MarketBeat's FREE daily newsletter.

PSNL Company Calendar

Last Earnings
11/04/2021
Today
2/04/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PSNL
Fax
N/A
Employees
325
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$13.00
High Stock Price Forecast
$24.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+233.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-65,230,000.00
Net Margins
-148.46%
Pretax Margin
-148.41%

Debt

Sales & Book Value

Annual Sales
$85.49 million
Book Value
$6.93 per share

Miscellaneous

Free Float
42,523,000
Market Cap
$179.28 million
Optionable
Not Optionable
Beta
1.53

Key Executives

  • Aaron TachibanaAaron Tachibana
    Chief Executive Officer
  • Christopher M. Hall
    President
  • Richard O. ChenRichard O. Chen
    Chief Medical Officer, SVP-Research & Development
  • Xavier Paliard
    Vice President-Immunology, Research & Development
  • Stephen M. Moore
    Secretary, Vice President & General Counsel













PSNL Stock - Frequently Asked Questions

Should I buy or sell Personalis stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PSNL shares.
View PSNL analyst ratings
or view top-rated stocks.

What is Personalis' stock price forecast for 2023?

4 analysts have issued 1-year price objectives for Personalis' stock. Their PSNL share price forecasts range from $6.00 to $24.00. On average, they predict the company's stock price to reach $13.00 in the next year. This suggests a possible upside of 233.3% from the stock's current price.
View analysts price targets for PSNL
or view top-rated stocks among Wall Street analysts.

How have PSNL shares performed in 2023?

Personalis' stock was trading at $1.98 at the start of the year. Since then, PSNL shares have increased by 97.0% and is now trading at $3.90.
View the best growth stocks for 2023 here
.

Are investors shorting Personalis?

Personalis saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 1,700,000 shares, an increase of 32.8% from the December 31st total of 1,280,000 shares. Based on an average daily volume of 379,000 shares, the short-interest ratio is presently 4.5 days. Currently, 4.7% of the company's shares are short sold.
View Personalis' Short Interest
.

When is Personalis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our PSNL earnings forecast
.

How were Personalis' earnings last quarter?

Personalis, Inc. (NASDAQ:PSNL) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.40) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.40). The business had revenue of $22.26 million for the quarter, compared to analyst estimates of $22.20 million. Personalis had a negative net margin of 148.46% and a negative trailing twelve-month return on equity of 37.12%. During the same quarter in the prior year, the firm posted ($0.27) EPS.

What guidance has Personalis issued on next quarter's earnings?

Personalis updated its fourth quarter 2022 earnings guidance on Wednesday, January, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $16.70 million-$16.70 million, compared to the consensus revenue estimate of $15.33 million.

What is John West's approval rating as Personalis' CEO?

17 employees have rated Personalis Chief Executive Officer John West on Glassdoor.com. John West has an approval rating of 75% among the company's employees.

What other stocks do shareholders of Personalis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Enphase Energy (ENPH), Pfizer (PFE), Dynavax Technologies (DVAX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), NIO (NIO), NVIDIA (NVDA), Viking Therapeutics (VKTX), AbbVie (ABBV) and

When did Personalis IPO?

(PSNL) raised $100 million in an initial public offering on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company served as the underwriters for the IPO and Oppenheimer was co-manager.

What is Personalis' stock symbol?

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Who are Personalis' major shareholders?

Personalis' stock is owned by many different retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (11.96%), Sumitomo Mitsui Trust Holdings Inc. (1.94%), Bank of Montreal Can (0.30%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aaron Tachibana, John Stephen West, Ken Ludlum, Lightspeed Venture Partners Se, Llp Abingworth, Richard Chen and Stephen Michael Moore.
View institutional ownership trends
.

How do I buy shares of Personalis?

Shares of PSNL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Personalis' stock price today?

One share of PSNL stock can currently be purchased for approximately $3.90.

How much money does Personalis make?

Personalis (NASDAQ:PSNL) has a market capitalization of $179.28 million and generates $85.49 million in revenue each year. The company earns $-65,230,000.00 in net income (profit) each year or ($2.26) on an earnings per share basis.

How many employees does Personalis have?

The company employs 325 workers across the globe.

How can I contact Personalis?

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The official website for the company is www.personalis.com. The company can be reached via phone at (650) 752-1300 or via email at investors@personalis.com.

This page (NASDAQ:PSNL) was last updated on 2/4/2023 by MarketBeat.com Staff